Is Early Second Trimester Vaginal Ultrasound Scan Associated With Adverse Perinatal Outcomes?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00909376|
Recruitment Status : Unknown
Verified May 2009 by Shaare Zedek Medical Center.
Recruitment status was: Not yet recruiting
First Posted : May 28, 2009
Last Update Posted : May 28, 2009
Many pregnant women have an ultrasound done of their fetus in the beginning of the second trimester of pregnancy. Some have a transvaginal sonography while others have a transabdominal one, depending on clinical parameters such as weight, scars etc. In the transvaginal ultrasound there is some amount of version of the fetus done by the examiner to maintain a better aspect of the fetus, while this is not done in a transabdominal sonography.
The objective of this trail is to determine whether having a transvaginal ultrasound as opposed to a transabdominal one has an association to adverse perinatal outcomes.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||450 participants|
|Official Title:||Is Early Second Trimester Vaginal Ultrasound Scan Associated With Adverse Perinatal Outcomes?|
|Study Start Date :||July 2009|
|Estimated Primary Completion Date :||December 2010|
|Estimated Study Completion Date :||December 2010|
1 - transabdominal sonography
Women who will have a transabdominal sonography done in the early second trimester.
2 - transvaginal sonography
Women who will have a transvaginal sonography done in the early second trimester.
- nuchal cord entanglement [ Time Frame: at birth ]
- SGA [ Time Frame: at birth ]
- Admission to intensive care unit [ Time Frame: at birth ]
- meconium [ Time Frame: at birth ]
- fetal distress [ Time Frame: at birth ]
- low APGAR score [ Time Frame: 1 minute, 5 minutes after birth ]
- need for c section [ Time Frame: at birth ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00909376
|Contact: Ori Shen, MD||972-2-6666666|
|Shaare Zedek Medical Center||Not yet recruiting|
|Principal Investigator:||Ori Shen, MD||Shaare Zedek Medical Center|